rs760665615
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000306749.4(FASN):c.1024G>T(p.Ala342Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,572,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000306749.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FASN | NM_004104.5 | c.1024G>T | p.Ala342Ser | missense_variant | 8/43 | ENST00000306749.4 | NP_004095.4 | |
FASN | XM_011523538.3 | c.1024G>T | p.Ala342Ser | missense_variant | 8/43 | XP_011521840.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FASN | ENST00000306749.4 | c.1024G>T | p.Ala342Ser | missense_variant | 8/43 | 1 | NM_004104.5 | ENSP00000304592 | P1 | |
FASN | ENST00000634990.1 | c.1024G>T | p.Ala342Ser | missense_variant | 8/43 | 5 | ENSP00000488964 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000508 AC: 9AN: 177226Hom.: 0 AF XY: 0.0000414 AC XY: 4AN XY: 96662
GnomAD4 exome AF: 0.0000197 AC: 28AN: 1420062Hom.: 0 Cov.: 37 AF XY: 0.0000213 AC XY: 15AN XY: 703230
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74368
ClinVar
Submissions by phenotype
Epileptic encephalopathy Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 23, 2023 | This variant is present in population databases (rs760665615, gnomAD 0.03%). This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 342 of the FASN protein (p.Ala342Ser). This variant has not been reported in the literature in individuals affected with FASN-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 575765). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.1024G>T (p.A342S) alteration is located in exon 8 (coding exon 7) of the FASN gene. This alteration results from a G to T substitution at nucleotide position 1024, causing the alanine (A) at amino acid position 342 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
FASN-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 25, 2024 | The FASN c.1024G>T variant is predicted to result in the amino acid substitution p.Ala342Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.025% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at